DOCSLIB.ORG

Objectives Overview of Stone Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Objectives Overview of Stone Disease 3/2/2014 Management of Urinary Tract Stones Debbie Sullivan, PhD, PA-C March 6, 2014 Objectives • Identify risk factors for developing urinary tract stones (UTS) • Recognize signs and symptoms associated with UTS • Compare and contrast diagnostic studies useful in evaluating the patient with UTS • Discuss indications and rationale for metabolic work- up of patients with stone disease • Describe medical and surgical management of stone disease Overview of Stone Disease UTS affects up to 12% of population during their lifetime Prevalence has increased annually over the past 5 years Third most common affliction of the urinary tract, exceeded only by infections and pathologic conditions of the prostate Recurrence rates approach 50% at 10 years Mortality is rare, although there is a 28% chance of renal deterioration with certain stone types 1 3/2/2014 Most Common Types of Stones Calcium oxalate Uric acid Struvite Cystine 2 3/2/2014 Risk Factors: Dietary/Lifestyle Diet high in animal protein, increase in fatty acids; decrease in fiber Dehydration/ low urine volume High sodium intake High temperatures Sedentary lifestyle; immobilization Family history of urinary stones Risk Factors: Metabolic Conditions Hypercalciuria Hyperoxaluria Hyperuricosuria Hypocitraturia Urine pH Acidic Alkaline Risk Factors: Disease States Metabolic acidosis Chronic diarrhea Inflammatory bowel disease Hyperparathyroidism Metabolic/obesity syndrome Sarcoidosis Medullary sponge kidney Adult polycystic kidney disease Pregnancy 3 3/2/2014 Risk Factors: Medications Vitamin C Vitamin D Triameterene Protease inhibitors: indinavir and nelfinavir Furosemide Acetazolamide Urisosuric agents: salicylates, probenecid Long term use of antacids containing silica Signs and Symptoms of UTS Renal colic: acute onset of severe colicky flank pain radiating to the groin or scrotum As stone descends, pain may localize to the abdomen As stone approaches the UVJ, pain may be more lower abdominal, with dysuria, urgency, frequency Infection may occur in presence of stone Cystitis Pyelonephritis or pyonephrosis Signs and Symptoms of UTS Gross or microscopic hematuria is present in ~90% of patients; however, absence of hematuria does not rule out stone Nausea and vomiting Fever Leukocytosis Sepsis: fever, tachycardia, hypotension Indicates medical emergency! 4 3/2/2014 Differential Diagnoses Renal, ureteral or bladder stone Hydronephrosis Bacterial cystitis or pyelonephritis Acute abdomen: appendicitis; bowel, biliary, pancreatic sources; AAA GYN: ectopic pregnancy, ovarian cyst or torsion Male: testicular torsion Radicular pain (sciatica, L1 herpes zoster) Referred pain (orchitis) Laboratory Studies Urinalysis: nitrites, leukocyte esterase Urine culture/sensitivity: even if UA negative Women: pregnancy test Hematologic tests: CBC BMP Diagnostic Imaging CT of abdomen and pelvis Non-contrast Detects most stones and screens for other conditions Renal ultrasound Includes kidneys and bladder May show hydronephrosis Plain KUB 5 3/2/2014 Metabolic Work-up Controversy over whether or not to get metabolic work up with first stone High risk patients should probably have metabolic work up: Pediatric stone formers Recurrent/chronic UTI Solitary kidney Family hx of stones Staghorn or multiple stones Gout, GI diseases associated with stones; bone disease Metabolic Work-up Stone analysis if recovered stone UA and urine culture 24 hour urine study: pH, volume, sodium, potassium, calcium, magnesium, phosphate, uric acid, oxalate, citrate, protein, creatinine and qualitative cystine Serum studies: sodium, potassium, bicarbonate, chloride, calcium, phostate, uric acid, alkaline phosphatase, creatinine, parathyroid hormone Indications for Acute Intervention Complete or high grade unilateral obstruction Any degree of bilateral obstruction Any degree of obstruction in patient with a solitary kidney Urinary infection or sepsis Any degree of obstruction with a rising creatinine Inability to tolerate liquids or oral medication Pain not controlled by oral analgesics 6 3/2/2014 Medical Management Trial of passage: reasonable where renal function is adequate, sufficient pain control, adequate oral intake, absence of infection and stone size < 10 mm Stone more likely to pass when located in distal ureter 70-80% of stones ≤ 5 mm will pass, mean time = 22 days Medical Management Oral hydration Oral pain medications Medical expulsion therapy (MET) NOT FDA APPROVED Patients undergoing trial of passage should be followed with periodic imaging to monitor stone position and assess for hydronephrosis Medical Expulsion Therapy (MET) Alpha-blockers Ureter contains alpha-1 receptors that mediate contraction of the ureteral smooth muscle, so alpha blockers relax the ureter smooth muscle Increases stone passage rate Decreases time to pass stone by 2-4 days Decreases pain during stone passage 7 3/2/2014 Medical Expulsion Therapy (MET) Tamsulosin (Flomax) has been most widely studied Terazosin (Hytrin) and doxazosin (Cardura) equally effective Calcium channel blockers have also been studied Nifidepine (Adalat, Procardia and others) Surgical Interventions Surgical interventions should be delayed until infection has resolved following appropriate antimicrobial therapy Interventions to relieve obstruction may be needed before definitive stone treatment Ureteral stent Percutaneous nephrostomy tube (PCN) Ureteral Stent •Temporary measure to bypass the obstruction to allow kidney to drain •Relieve pain from hydronephrosis •May cause lower urinary tract symptoms •After definitive stone treatment, stent has to be removed •Stent may be placed in conjunction with ESWL or ureteroscopic laser lithotripsy •Complications: stent migration, UTI, breakage, encrustation, obstruction 8 3/2/2014 Percutaneous Nephrostomy (PCN) Conscious sedation; usually done by Interventional Radiologist External drainage bag will require minimal care Potential source for infection Need to exchange on a regular basis if in longer than 4 weeks Surgical Interventions Extracorporal Shock Wave Lithotripsy (ESWL) Ureteroscopic stone extraction Percutaneous nephrolithotomy Open stone extraction ESWL Non-invasive; general anesthesia; outpatient procedure Absolute contraindications: Pregnancy Coagulopathy UTI Renal artery or abdominal aorta aneurysm Intrarenal vascular calcifications near shock wave focus 9 3/2/2014 Potential Complications Renal or retroperitoneal hematoma Ecchymosis or petechiae UTI: 5% Sepsis: < 3% Steinstrasse (“stone street”) 4-8% Ureteral stricture – < 2% Ureteroscopic Stone Extraction Requires general anesthesia Extraction of lower ureteral calculus Baskets and graspers may be used Stone-free rates approach 95% Variety of lithotrites, such as Holmium laser, placed through the ureteroscope to fragment stones Stenting following ureteroscopy is optional Potential Complications Ureteral avulsion: ≤ 0.5% Ureteral perforation: < 5% Submucosal tunneling: < 5% Stricture: 1% UTI: < 4% Bleeding and pain 10 3/2/2014 Percutaneous Nephrolithotomy (PCNL) PCNL removes stone through percutaneous access that traverses through the back and into the kidney Treatment of choice for renal or proximal ureteral stones or staghorn calculi Indicated if failure of other treatments, renal stones > 2 cm, stone in calyceal diverticulum or UPJ obstruction with stone Contraindications to PCNL UTI/sepsis Coagulopathy Safe renal access not possible Potential Complications Bleeding: risk of transfusion 3% Sepsis Renal pelvis perforation Pneumothorax/hydrothorax Intraperitoneal injury 11 3/2/2014 Bladder Stones Cystoscopic extraction Bladder irrigation reserved for patients who cannot tolerate or who refuse surgical removal Men with bladder stones and enlarged prostate at increased risk for Bladder Outlet Obstruction; may need prostate treatment in conjunction with cystoscopy or cystolithopaxy Stone Prevention Hydrate, hydrate, hydrate! Limit sodium in diet Alkalinizing agents: potassium citrate, 60 mEq 3 or 4 times daily for those with hypocitraturia Uric acid lowering agents if hyperuricosuric (allipurinol) Absorption inhibitor: cellulose phosphate for patients with absorptive hypercalciuria Diuretics: thiazides can correct renal calcium leak Summary Points Infection must be adequately treated before stone removal procedure is undertaken Obstruction is an indication for immediate intervention Bilateral obstruction is a urologic emergency Without prevention, 50% of patients will have recurrent stone disease within 5 years 12 3/2/2014 Questions? 13.
Load more

Recommended publications
  • Leukocyte Esterase Activity in Vaginal Fluid of Pregnant and Non-Pregnant Women with Vaginitis/Vaginosis and in Controls
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Infect Dis Obstet Gynecol 2003;11:19–26 Leukocyte esterase activity in vaginal fluid of pregnant and non-pregnant women with vaginitis/vaginosis and in controls Per-Anders Mårdh 1, Natalia Novikova 1, Ola Niklasson 1, Zoltan Bekassy 1 and Lennart Skude 2 1Department of Obstetrics and Gynecology, University Hospital, Lund and 2Department of Clinical Chemistry, County Hospital, Halmstad, Sweden Objectives: Todeterminethe leukocyteesterase (LE) activity invaginal lavage fluid ofwomen with acuteand recurrentvulvovaginal candidosis (VVC and RVVC respectively), bacterial vaginosis(BV), and in pregnant and non-pregnantwomen without evidenceof the threeconditions. Also tocompare the resultof LEtestsin women consultingat differentweeks inthe cycle andtrimesters of pregnancy.The LEactivity was correlatedto vaginal pH, numberof inflammatory cells instained vaginal smears,type of predominatingvaginal bacteria andpresence of yeast morphotypes. Methods: Onehundred and thirteen women with ahistoryof RVVC,i.e. with at least fourattacks of the conditionduring the previousyear and who had consultedwith anassumed new attack ofthe condition,were studied.Furthermore, we studied16 women with VVC,15 women with BV,and 27 women attendingfor control of cytological abnormalities, who all presentedwithout evidenceof either vaginitisor vaginosis. Finally, 73 pregnantwomen wereinvestigated. The LEactivity invaginal fluid duringdifferent weeks inthe cycle of 53 of the women was measured. Results: Inthe non-pregnantwomen, anincreased LE activity was foundin 96, 88, 73 and56% of those with RVVC,VVC and BV andin the non-VVC/BVcases,respectively. In 73% of pregnantwomen inthe second trimester,and 76% of thosein the third,the LEtestwas positive.In all groupsof non-pregnantwomen tested, the LEactivity correlatedwith the numberof leukocytesin vaginal smears,but it didnot in those who were pregnant.There was nocorrelation between LE activity andweek incycle.
    [Show full text]
  • Ileal Neobladder: an Important Cause of Non-Anion Gap Metabolic Acidosis
    The Journal of Emergency Medicine, Vol. 52, No. 5, pp. e179–e182, 2017 Ó 2017 Elsevier Inc. All rights reserved. 0736-4679/$ - see front matter http://dx.doi.org/10.1016/j.jemermed.2016.12.036 Clinical Communications: Adult ILEAL NEOBLADDER: AN IMPORTANT CAUSE OF NON-ANION GAP METABOLIC ACIDOSIS Jesse W. St. Clair, MD and Matthew L. Wong, MD, MPH Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts and Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts Reprint Address: Matthew L. Wong, MD, MPH, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Rosenberg Building, 2nd Floor, 1 Deaconess Road, Boston, MA 02446 , Abstract—Background: The differential diagnosis for a disease, or medications such as acetazolamide. non-anion gap metabolic acidosis is probably less well Commonly used mnemonics to remember the differential known than the differential diagnosis for an anion gap for the non-anion gap metabolic acidosis include metabolic acidosis. One etiology of a non-anion gap acidosis ‘‘ABCD’’ for ‘‘Addison’s, Bicarbonate loss, Chloride is the consequence of ileal neobladder urinary diversion (administration), and Drugs,’’ as well as ‘‘HARDUP’’ for the treatment of bladder cancer. Case Report: We pre- for ‘‘Hyperchloremia, Acetazolamide and Addison’s, sent a case of a patient with an ileal neobladder with a severe non-anion gap metabolic acidosis caused by a Renal Tubular Acidosis, Diarrhea, Ureteroenterostomies, urinary tract infection and ureteroenterostomy. Why and Pancreaticoenterostomies’’ (Table 1) (1). Should an Emergency Physician Be Aware of This?: Part Ureteroenterostomies are when the ureter has an of the ileal neobladder surgery includes ureteroenteros- abnormal connection with a segment of intestine.
    [Show full text]
  • Bladder Stones in Dogs & Cats By: Dr
    Navarro Small Animal Clinic 5009 Country Club Dr. Victoria, TX 77904 361-573-2491 www.navarrosmallanimalclinic.com Bladder Stones in Dogs & Cats By: Dr. Shana Bohac Dogs, like people, can develop a variety of bladder stones. These stones are rock-like structures that are formed by minerals. Some stones form in alkaline urine, whereas others form when the urine is more acidic. Bladder stones are very common in dogs, particularly small breed dogs. The most common signs that a dog or cat has bladder stones include blood in the urine, and straining to urinate. Blood is seen due to the stones bouncing around and hitting the bladder wall. This can irritate and damage the tissue and can cause cystitis (inflammation of the bladder). Straining to urinate occurs because of the inflammation and irritation of the bladder walls or urethra or muscle spasms. The stone itself can actually obstruct the flow of urine if it blocks the urethra. Small stones can get stuck in the urethra and cause a complete obstruction. This can be life threatening if the obstruction is not relieved since the bladder can rupture as more urine is produced with nowhere to go. Bladder stones form because of changes in the urine pH. Normal dog urine is slightly acidic and contains waste products such as dissolved minerals and enzymes such as urease. Urease breaks down excess ammonia in urine. An overload of ammonia in urine can cause bladder inflammation and thickening known as cystitis. There are a variety of stones that can form in the bladder, some that form in acidic urine, while others form in alkaline urine.
    [Show full text]
  • EAU Guidelines on Bladder Stones 2019
    EAU Guidelines on Bladder Stones C. Türk (Chair), A. Skolarikos (Vice-chair), J.F. Donaldson, A. Neisius, A. Petrik, C. Seitz, K. Thomas Guidelines Associate: Y. Ruhayel © European Association of Urology 2019 TABLE OF CONTENTS PAGE 1. INTRODUCTION 3 1.1 Aims and Scope 3 1.2 Panel Composition 3 1.3 Available Publications 3 1.4 Publication History and Summary of Changes 3 1.4.1 Publication History 3 2. METHODS 3 2.1 Data Identification 3 2.2 Review 4 3. GUIDELINES 4 3.1 Prevalence, aetiology and risk factors 4 3.2 Diagnostic evaluation 4 3.2.1 Diagnostic investigations 5 3.3 Disease Management 5 3.3.1 Conservative treatment and Indications for active stone removal 5 3.3.2 Medical management of bladder stones 5 3.3.3 Bladder stone interventions 5 3.3.3.1 Suprapubic cystolithotomy 5 3.3.3.2 Transurethral cystolithotripsy 5 3.3.3.2.1 Transurethral cystolithotripsy in adults: 5 3.3.3.2.2 Transurethral cystolithotripsy in children: 6 3.3.3.3 Percutaneous cystolithotripsy 6 3.3.3.3.1 Percutaneous cystolithotripsy in adults: 6 3.3.3.3.2 Percutaneous cystolithotripsy in children: 6 3.3.3.4 Extracorporeal shock wave lithotripsy (SWL) 6 3.3.3.4.1 SWL in Adults 6 3.3.3.4.2 SWL in Children 6 3.3.4 Treatment for bladder stones secondary to bladder outlet obstruction (BOO) in adult men 7 3.3.5 Urinary tract reconstructions and special situations 7 3.3.5.1 Neurogenic bladder 7 3.3.5.2 Bladder augmentation 7 3.3.5.3 Urinary diversions 7 4.
    [Show full text]
  • Evaluation of Gross and Microscopic Hematuria
    EVALUATION OF GROSS AND MICROSCOPIC HEMATURIA APRIL GARDNER, MSBS, PA - C ASSOCIATE PROGRAM DIRECTOR THE UNIVERSITY OF TOLEDO PA PROGRAM OBJECTIVES • Define the terms gross hematuria and microscopic hematuria. • Identify etiologies of hematuria. • Identify risk factors for a urologic cancer in a patient with gross or microscopic hematuria. • Define the term “full evaluation.” • Identify indications for a full evaluation. • Identify labs and diagnostics to evaluate hematuria. • Identify the appropriate follow-up for patients with hematuria. 2 CASE #1 Ms. T is a healthy 50 year-old female, s/p TAH/BSO 15 years ago for severe endometriosis. She presents today for her annual physical exam required by her employer. She has no new complaints and there is no history of any urologic complaints. Physical exam is completely normal Urine dipstick shows 1+ blood, pH 6.0, negative for ketones, glucose, nitrites and leukocyte esterase Microscopic evaluation shows 8 RBCs, no WBCs, bacteria, yeast, crystals, or casts CASE #1 • Should you prescribe an antibiotic for Ms. T today? • Does she need any further follow-up? • If yes, what would follow-up include? CASE #2 Mr. D is a 38 year-old healthy, monogamous married male with 4 children, presenting for a vasectomy consultation. He denies any complaints, including urologic complaints. He takes no medications. He tells you he ran a marathon 2 days ago and then finished building a deck in his backyard yesterday. Physical exam is completely normal Urine dipstick shows 1+ blood, pH 6.0, negative for protein, ketones, glucose, nitrites and leukocyte esterase Microscopic evaluation shows 3 RBCs, no WBCs, bacteria, yeast, crystals, or casts CASE #2 • Should you prescribe an antibiotic for Mr.
    [Show full text]
  • The Use of the Bladder Wash-Out Test in Patients with Spinal Cord Lesions Who Have Urinary Tract Infection*
    Paraplegia 2I (1983) 294-300 © 1983 International Medical Society of Paraplegia THE USE OF THE BLADDER WASH-OUT TEST IN PATIENTS WITH SPINAL CORD LESIONS WHO HAVE URINARY TRACT INFECTION* By J. J. WYNDAELE, M.D., W. OOSTERLINCK, M.D., W. A. DE Sy, M. D. and H. CLAESSENS, M. D. Department of Urology and Rehabilitation Centre, University of Ghent, Belgium Summary. In 42 patients with a spinal cord lesion and chronic urinary tract infection the bladder wash-out test was performed to locate the site of infection. The test was easy to perform and no complications occurred. The test could not be performed in only one patient. Differentiation between upper and lower urinary tract infection was possible in 36 patients (43 tests). By using the test, precise treatment was possible for 23 patients, of whom 17 were cured. Key words: Spinal cord lesions; Bladder wash-out test; Urinary tract infection. Introduction To KNOW the exact site of infection may be a very important factor in the correct management of patients with urinary tract infection. Chronic or recurrent urinary tract infections are frequent in patients with spinal cord lesions. Localisation of the infection in these patients may be the clue to a definite diagnosis, and proper treatment. Among other, procedures, the bladder wash-out test has been pro­ posed as a technique which makes differentiation between upper and lower urinary tract infection possible. The purpose of this study is to evaluate its usefulness in patients with spinal cord lesions and chronic or recurrent urinary tract infection. Methods We perform the bladder wash-out test approximately as described by Fairley and associates (Fairley et al., 1967).
    [Show full text]
  • Storm in a Pee Cup: Hematuria and Proteinuria
    Storm in a Pee Cup: Hematuria and Proteinuria Sudha Garimella MD Pediatric Nephrology, Children's Hospital-Upstate Greenville SC Conflict of Interest • I have no financial conflict of interest to disclose concerning this presentation. Objectives • Interpret the current guidelines for screening urinalysis, and when to obtain a urinalysis in the pediatric office. • Interpret the evaluation of asymptomatic/isolated proteinuria and definitions of abnormal ranges. • Explain the evaluation and differential diagnosis of microscopic hematuria. • Explain the evaluation and differential diagnosis of gross hematuria. • Explain and discuss appropriate referral patterns for hematuria. • Racial disparities in nephrology care 1. APOL-1 gene preponderance in African Americans and risk of proteinuria /progression(FSGS) 2. Race based GFR calculations which have caused harm 3. ACEI/ARB usage in AA populations: myths and reality Nephrology Problems in the Office • Hypertension • Proteinuria • Microscopic Hematuria • Abnormal Renal function The Screening Urinalysis • Choosing Wisely: • Don’t order routine screening urine analyses (UA) in healthy, asymptomatic pediatric patients as part of routine well child care. • One study showed that the calculated false positive/transient abnormality rate approaches 84%. • Population that deserves screening UA: • patients who are at high risk for chronic kidney disease (CKD), including but not necessarily limited to patients with a personal history of CKD, acute kidney injury (AKI), congenital anomalies of the urinary tract, acute nephritis, hypertension (HTN), active systemic disease, prematurity, intrauterine growth retardation, or a family history of genetic renal disease. • https://www.choosingwisely.org/societies/american-academy-of-pediatrics-section-on- nephrology-and-the-american-society-of-pediatric-nephrology/ Screening Urinalysis: Components A positive test for leukocyte esterase may be seen in genitourinary inflammation, irritation from instrumentation or catheterization, glomerulonephritis, UTIs and sexually transmitted infections.
    [Show full text]
  • Treatment and Prevention of Calcium Oxalate Kidney and Bladder Stones
    Treatment and prevention of calcium oxalate Leslie Bean with Fuzzerbear kidney and bladder stones Adapted from an article by CJ Puotinen and Mary Straus, published in the Whole Dog Journal, May 2010 Bladder and kidney stones are serious problems in dogs as well as people. These conditions – which are also known as uroliths or urinary calculi – can be excruciatingly painful as well as potentially fatal. Fortunately, informed caregivers can do much to prevent the formation of stones and in some cases actually help treat stones that develop. In this article, we examine calcium oxalate or CaOx stones. CaOx stones occur in both the bladder (lower urinary tract) and kidneys (upper urinary tract) of male and female dogs. Most calcium oxalate uroliths are nephroliths (found in the kidney), and most of the affected patients are small-breed males. CaOx uroliths are radiopaque, meaning that they are easily seen on radiographs (X- rays). Twenty-five years ago, struvites were the most common uroliths collected from canine patients, representing almost 80 percent of the total, while only 5 percent were calcium oxalate stones. The percentage of struvite uroliths found has declined while that of CaOx stones has risen, so that nearly half of all canine uroliths analyzed today are calcium oxalate stones. It’s unknown whether the incidence of struvite stones has decreased or if the change is due solely to an increase in calcium oxalate uroliths. Similar changes have occurred in cats, but in that case, we have a good idea why. Twenty years ago, calcium oxalate stones were virtually unheard of in cats, who commonly formed sterile struvites.
    [Show full text]
  • Ultrasound Findings of the Urinary Tract in Patients with Spinal Cord
    Spinal Cord (2015) 53, 139–144 & 2015 International Spinal Cord Society All rights reserved 1362-4393/15 www.nature.com/sc ORIGINAL ARTICLE Ultrasound findings of the urinary tract in patients with spinal cord injury: a study of 1005 cases Ü Güzelküçük, Y Demir, S Kesikburun, B Aras, E Yaşar and AK Tan Study design: Retrospective chart review. Objectives: To document urinary tract abnormalities (UTAs) in patients with spinal cord injury (SCI) and to assess demographic and clinical features associated with UTA detected via ultrasound (US). Setting: Turkish Armed Forces Rehabilitation Center, Ankara, Turkey. Methods: The medical and radiological records of all patients with SCI were screened. Variables in each patient with SCI, including age at the time of the US examination, gender, etiology, level and severity of SCI, time since injury, bladder management methods and findings of urinary tract US, were reviewed and analyzed. Results: Data were obtained from 1005 patients during the 6-year study period (2008–2013). The mean age was 35.67 ± 14.79 years and the male–female ratio was 2.84:1. Trabeculated bladder (TB) was observed in 35.1% of the patients, bladder calculi in 6%, renal calculi in 6%, hydronephrosis in 5.5% and renal atrophy in 1.2%. Bladder calculi, renal calculi and renal atrophy were observed in patients with TB at higher rates than in those without TB (P = 0.001, 0.036 and 0.004, respectively). The association of TB with hydronephrosis was very close to significance level (P = 0.052). Conclusion: A large number of SCI patients had UTAs including TB, renal and bladder calculi, hydronephrosis and renal atrophy.
    [Show full text]
  • Oxalate Bladder Stones (Canine) - Veterinarypartner.Com - a VIN Company! Page 1 of 3
    01 Oxalate Bladder Stones (Canine) - VeterinaryPartner.com - a VIN company! Page 1 of 3 Home » Oxalate Bladder Stones (Canine) THE PET HEALTH LIBRARY By Wendy C. Brooks, DVM, DipABVP Educational Director, VeterinaryPartner.com Oxalate Bladder Stones (Canine) Oxalate Bladder Stones in Dogs • 73% of calcium oxalate patients are male. This stone type is unusual in females. • Breeds at especially high risk include: miniature schnauzers, Lhasa Apsos, Yorkshire terriers, miniature poodles, shih tzus, and Bichon frises. • Most cases occur in dogs between ages 5 and 12 years of age. How do we know these are Calcium Oxalate Stones? Although a urinalysis can provide a clue, the only way to know for sure that a dog’s bladder stone is an oxalate stone is to retrieve a stone and have a laboratory analyze it. If the stones are very small, flushing the urinary bladder and forcefully expressing it may produce a stone sample for testing. The only other way to obtain a sample is to surgically open the bladder and remove the stones. The surgical method is invasive but provides the most rapid resolution of the bladder stone issue. Calcium oxalate stones cannot be made to dissolve over time by changing to a special diet, as can be done with struvite or uric acid bladder stones. Each division of these bladder stones Why would my Dog Form Calcium Oxalate Stones? = 1 millimeter It shouldn’t be too surprising that there is a strong hereditary component to the formation of oxalate bladder stones. This is also true in humans. There is a substance called nephrocalcin in urine that naturally inhibits the formation of calcium oxalate stones.
    [Show full text]
  • Canine Kidney Stone and Bladder Stone Prevention | Whole Dog Journal
    Canine Kidney Stone and Bladder Stone Prevention | Whole Dog Journal https://www.whole-dog-journal.com/issues/13_4/features/Detecting-Urin... Canine Kidney Stone and Bladder Stone Prevention How to prevent and treat your dog's struvite crystals and stones. By CJ Puotinen, Mary Straus [Updated August 6, 2018] URINARY STONES IN DOGS: OVERVIEW 1. Become familiar with the symptoms of urinary stones and respond quickly if you see them. 2. Request a urine culture and sensitivity test to check for infection even if your veterinarian doesn't think it's necessary. 3. Encourage your dog to drink extra water and give her frequent opportunities to urinate. 4. Don't expect a low-protein diet to cure or prevent struvite stones. 5. Learn how to test your dog's pH to check for recurring urinary tract infections. Humans aren’t the only ones who get kidney and bladder stones. Our dogs develop these painful and dangerous conditions, too. But much of what is said and done about canine urinary tract stone disease (also known as bladder stones, urolithiasis, urinary stones, ureteral stones, urinary calculi, ureteral calculi, or urinary calculus disease), including its causes and treatment, is either incorrect, ineffective, or potentially harmful. Here’s the information you need in order to make informed decisions on behalf of your best friend. Most canine uroliths, or bladder stones, fall into six categories, depending on their mineral composition: • Magnesium ammonium phosphate (also called struvites) • Calcium oxalate • Ammonium urate or uric acid • Cystine • Calcium phosphate • Silica 1 of 13 11/1/2018, 7:58 PM Canine Kidney Stone and Bladder Stone Prevention | Whole Dog Journal https://www.whole-dog-journal.com/issues/13_4/features/Detecting-Urin..
    [Show full text]
  • Leukocyte Esterase Activity in Vaginal Fluid of Pregnant and Non-Pregnant Women with Vaginitis/Vaginosis and in Controls
    Infect Dis Obstet Gynecol 2003;11:19–26 Leukocyte esterase activity in vaginal fluid of pregnant and non-pregnant women with vaginitis/vaginosis and in controls Per-Anders Mårdh 1, Natalia Novikova 1, Ola Niklasson 1, Zoltan Bekassy 1 and Lennart Skude 2 1Department of Obstetrics and Gynecology, University Hospital, Lund and 2Department of Clinical Chemistry, County Hospital, Halmstad, Sweden Objectives: Todeterminethe leukocyteesterase (LE) activity invaginal lavage fluid ofwomen with acuteand recurrentvulvovaginal candidosis (VVC and RVVC respectively), bacterial vaginosis(BV), and in pregnant and non-pregnantwomen without evidenceof the threeconditions. Also tocompare the resultof LEtestsin women consultingat differentweeks inthe cycle andtrimesters of pregnancy.The LEactivity was correlatedto vaginal pH, numberof inflammatory cells instained vaginal smears,type of predominatingvaginal bacteria andpresence of yeast morphotypes. Methods: Onehundred and thirteen women with ahistoryof RVVC,i.e. with at least fourattacks of the conditionduring the previousyear and who had consultedwith anassumed new attack ofthe condition,were studied.Furthermore, we studied16 women with VVC,15 women with BV,and 27 women attendingfor control of cytological abnormalities, who all presentedwithout evidenceof either vaginitisor vaginosis. Finally, 73 pregnantwomen wereinvestigated. The LEactivity invaginal fluid duringdifferent weeks inthe cycle of 53 of the women was measured. Results: Inthe non-pregnantwomen, anincreased LE activity was foundin 96, 88, 73 and56% of those with RVVC,VVC and BV andin the non-VVC/BVcases,respectively. In 73% of pregnantwomen inthe second trimester,and 76% of thosein the third,the LEtestwas positive.In all groupsof non-pregnantwomen tested, the LEactivity correlatedwith the numberof leukocytesin vaginal smears,but it didnot in those who were pregnant.There was nocorrelation between LE activity andweek incycle.
    [Show full text]